You searched for "screening"
Pupil responses in diabetes
4 February 2021
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Diabetes mellitus, Diabetic retinopathy, dynamic pupillometry, pupil diameter, static pupillometry
This study aimed to investigate pupillary involvement in patients with type 2 diabetes mellitus (DM) and to evaluate any relationship between severity of diabetic retinopathy (DR) and pupillary responses. Participants included 133 individuals in four groups: proliferative DR (n=21), non-proliferative...
Clinical predictors of proliferative sickle cell retinopathy
29 March 2024
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
Sickle Cell Disease (SCD) is an inherited disorder resulting in production of Haemoglobin S (HbS), which aggregates in conditions of hypoxia, acidosis or hyperosmolarity. This leads to vascular stasis, thrombosis and ischaemia. The authors present a cross-sectional study (45 consecutive...
Vigabatrin-induced retinal toxicity detected by 30Hz ERG
The purpose of this study was to assess the role of 30Hz flicker electroretinogram (ERG) as a marker for measuring changes in visual function over time in children receiving vigabatrin. This was an observational study of 11 children with mean...CooperVision’s plastic neutrality initiative reaches remarkable half-billion bottle milestone
CooperVision recently announced a significant milestone in its pioneering plastic neutrality initiative. The multi-continent programme – in collaboration with Plastic Bank®, eyecare professionals, and contact lens wearers – has now prevented the equivalent of more than half a billion plastic...
Effects of phacoemulsification on IOP and drug use in glaucoma
1 December 2017
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
For patients with comorbid cataract and primary open-angle glaucoma (POAG), guidance is lacking as to whether cataract extraction and traditional filtering surgery should be performed as a staged or combined procedure. Achieving this guidance requires an evidence-based understanding of the...
Germline testing for uveal melanoma
4 December 2023
| Ian Reekie
|
EYE - Pathology, EYE - Oncology
|
BAP1, Uveal melanoma, genetic counselling, hereditary cancer, mainstreaming, service delivery
The authors present a study of 114 consecutive patients presenting with uveal melanoma. Between 1 December 2019 and 1 November 2021 all patients over 18-years-old presenting to their centre with uveal melanoma were offered germline testing for variants in BAP1,...
Long-term open angle glaucoma cohort study
1 December 2014
| Nana Theodorou
|
EYE - Glaucoma
This was a study to estimate the development of open angle glaucoma (OAG) in a screened and re-examined elderly group as compared to an unscreened group during the same time period. The participants comprised of 856 individuals born in 1915...
Caring for adults with an ocular tumour
1 December 2015
| Bertil E Damato
|
EYE - Vitreo-Retinal
Detection If you screen for an intraocular tumour, dilate the pupil. If the patient is driving, use phenylephrine only. If the patient declines, document this in the casenotes. Don’t forget to look for sentinel vessels, which would indicate a ciliary...
Idiopathic orbital pseudotumor as first sign of systemic inflammatory disease
The authors describe four children in whom idiopathic orbital pseudotumor (IOP) was the initial solitary finding with systemic inflammatory disease developing later. Four children were seen over a five-year period. Mean age was 9.75 years (2-14). Three were white and...Professor Roy Taylor awarded MBE for services to diabetes research
20 January 2023
Congratulations to Diabetes UK-funded researcher Professor Roy Taylor, who has been awarded an MBE in the New Year Honours list, recognising his world-leading work in diabetes research.
Appeal for fundus cameras and OCT machines for Nigeria
29 January 2021
Nigeria has the highest population of people living with diabetes mellitus (DM) in sub-Saharan Africa. As at 2013 the population of people living with DM stood at 4.9 million, of whom an estimated 1.7 million had diabetic retinopathy (DR). There is currently no national DR screening and treatment programme.
